Christopher R. Logg

1.1k total citations
27 papers, 886 citations indexed

About

Christopher R. Logg is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Christopher R. Logg has authored 27 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Genetics and 7 papers in Biotechnology. Recurrent topics in Christopher R. Logg's work include Virus-based gene therapy research (20 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (8 papers). Christopher R. Logg is often cited by papers focused on Virus-based gene therapy research (20 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (8 papers). Christopher R. Logg collaborates with scholars based in United States, Japan and France. Christopher R. Logg's co-authors include Noriyuki Kasahara, Kei Hiraoka, Chien-Kuo Tai, Nathan A. Lemp, Takahiro Kimura, W. French Anderson, Baruch Frenkel, Rebecca Redman, Gerhard A. Coetzee and Elisheva Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Christopher R. Logg

26 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. Logg United States 19 630 543 273 104 82 27 886
Juraj Hlavatý Austria 13 425 0.7× 392 0.7× 226 0.8× 88 0.8× 78 1.0× 33 722
Paul Shabram United States 12 740 1.2× 578 1.1× 322 1.2× 100 1.0× 69 0.8× 21 1.0k
T von Rüden Austria 11 946 1.5× 607 1.1× 344 1.3× 83 0.8× 174 2.1× 15 1.3k
Hédi Haddada France 24 725 1.2× 577 1.1× 522 1.9× 129 1.2× 293 3.6× 50 1.2k
Gilliane Chadeuf France 14 604 1.0× 531 1.0× 169 0.6× 42 0.4× 27 0.3× 29 822
Jacqueline Kintz France 11 331 0.5× 429 0.8× 252 0.9× 104 1.0× 118 1.4× 11 618
Dong‐Soo Im South Korea 16 845 1.3× 540 1.0× 232 0.8× 61 0.6× 73 0.9× 30 1.3k
Justin C. Roth United States 14 403 0.6× 392 0.7× 394 1.4× 46 0.4× 156 1.9× 25 800
B.C. Trapnell United States 4 453 0.7× 526 1.0× 212 0.8× 49 0.5× 100 1.2× 9 760
Kilian Guse Finland 22 717 1.1× 781 1.4× 570 2.1× 226 2.2× 127 1.5× 32 1.3k

Countries citing papers authored by Christopher R. Logg

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Logg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Logg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Logg more than expected).

Fields of papers citing papers by Christopher R. Logg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Logg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Logg. The network helps show where Christopher R. Logg may publish in the future.

Co-authorship network of co-authors of Christopher R. Logg

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Logg. A scholar is included among the top collaborators of Christopher R. Logg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Logg. Christopher R. Logg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Amy, Christopher R. Logg, Yanzheng Liu, et al.. (2014). MicroRNA 142-3p Attenuates Spread of Replicating Retroviral Vector in Hematopoietic Lineage-Derived Cells While Maintaining an Antiviral Immune Response. Human Gene Therapy. 25(8). 759–771. 4 indexed citations
3.
4.
Lemp, Nathan A., et al.. (2013). Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cells.. PubMed. 93–101.
5.
Logg, Christopher R., Joan M. Robbins, Douglas J. Jolly, Harry E. Gruber, & Noriyuki Kasahara. (2012). Retroviral Replicating Vectors in Cancer. Methods in enzymology on CD-ROM/Methods in enzymology. 507. 199–228. 18 indexed citations
6.
Perez, Omar D., Christopher R. Logg, Kei Hiraoka, et al.. (2012). Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression. Molecular Therapy. 20(9). 1689–1698. 112 indexed citations
7.
Lemp, Nathan A., Kei Hiraoka, Noriyuki Kasahara, & Christopher R. Logg. (2012). Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory function. Nucleic Acids Research. 40(15). 7280–7290. 25 indexed citations
8.
Wang, Wenxue, Christopher R. Logg, William B. Parker, et al.. (2010). Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Therapy. 17(9). 614–623. 35 indexed citations
9.
Kimura, Takahiro, Kei Hiraoka, Noriyuki Kasahara, & Christopher R. Logg. (2010). Optimization of enzyme–substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases. The Journal of Gene Medicine. 12(6). 528–537. 30 indexed citations
10.
Tomioka, Atsushi, Chun‐Peng Liao, Takahiro Kimura, et al.. (2008). PTEN Knockout Prostate Cancer as a Model for Experimental Immunotherapy. The Journal of Urology. 181(1). 354–362. 5 indexed citations
11.
Logg, Christopher R., et al.. (2007). Adaptive Evolution of a Tagged Chimeric Gammaretrovirus: Identification of Novel cis-Acting Elements that Modulate Splicing. Journal of Molecular Biology. 369(5). 1214–1229. 23 indexed citations
12.
13.
Lemp, Nathan A., Christopher R. Logg, German G. Gomez, et al.. (2006). Permanent, Lowered HLA Class I Expression Using Lentivirus Vectors With shRNA Constructs: Averting Cytotoxicity by Alloreactive T Lymphocytes. Transplantation Proceedings. 38(10). 3184–3188. 25 indexed citations
14.
Dalba, Charlotte, David Klatzmann, Christopher R. Logg, & Noriyuki Kasahara. (2005). Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors. Current Gene Therapy. 5(6). 655–667. 39 indexed citations
15.
Logg, Christopher R. & Noriyuki Kasahara. (2004). Retrovirus-Mediated Gene Transfer to Tumors: Utilizing the Replicative Power of Viruses to Achieve Highly Efficient Tumor Transduction In Vivo. Humana Press eBooks. 246. 499–526. 15 indexed citations
16.
Tai, Chien-Kuo, Christopher R. Logg, Jinha Park, et al.. (2003). Antibody-Mediated Targeting of Replication-Competent Retroviral Vectors. Human Gene Therapy. 14(8). 789–802. 37 indexed citations
17.
Soifer, Harris S., Christopher R. Logg, Lily Jih, et al.. (2002). A Novel, Helper-Dependent, Adenovirus–Retrovirus Hybrid Vector: Stable Transduction by a Two-Stage Mechanism. Molecular Therapy. 5(5). 599–608. 27 indexed citations
18.
Soifer, Harris S., et al.. (2002). A Novel, Helper-Dependent, Adenovirus–Retrovirus Hybrid Vector: Stable Transduction by a Two-Stage Mechanism. Molecular Therapy. 6(1). 135–135. 2 indexed citations
19.
Logg, Christopher R., et al.. (2001). A Uniquely Stable Replication-Competent Retrovirus Vector Achieves Efficient Gene Delivery in Vitro and in Solid Tumors. Human Gene Therapy. 12(8). 921–932. 66 indexed citations
20.
Smith, Elisheva, Rebecca Redman, Christopher R. Logg, et al.. (2000). Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. Journal of Biological Chemistry. 275(26). 19992–20001. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juraj Hlavatý Breakdown of academic impact, for papers by Paul Shabram Breakdown of academic impact, for papers by T von Rüden Breakdown of academic impact, for papers by Hédi Haddada Breakdown of academic impact, for papers by Gilliane Chadeuf Breakdown of academic impact, for papers by Jacqueline Kintz Breakdown of academic impact, for papers by Dong‐Soo Im Breakdown of academic impact, for papers by Justin C. Roth Breakdown of academic impact, for papers by B.C. Trapnell Breakdown of academic impact, for papers by Kilian Guse
Rankless by CCL
2026